Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label canadian patient safety. Show all posts
Showing posts with label canadian patient safety. Show all posts
Tuesday, March 06, 2012

open access: British Journal of Cancer - Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer (safety, adverse events, disease progression, conflicting research.....)

›
Blogger's Note: note ties to industry                             ````````````````````````````````` "Erythropoiesis-stimulatin...
Tuesday, February 07, 2012

CMAJ: Private rooms: A choice between infection and profit

›
Monday, January 23, 2012

abstract: The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer (phase 1)

›
Purpose: This study evaluated the clinical relevance of the dual-targeting strategy involving PI3K/AKT/mTOR and RAF/...
Saturday, January 21, 2012

New York Times - News Analysis - "I Disclose ... Nothing" (patient safety communities ??)

›
"........One fundamental problem is that disclosure requirements merely get information onto the table, but themselves demand no furth...
Sunday, August 28, 2011

genetics? patient safety? ovarian cancer survival? ethics? links & references - Survivors' Debate: The Past Decade in Ovarian Cancer 'CON' side of debate Sandi Pniauskas

›
...
Friday, June 17, 2011

(from asco 2011) video: Dr Steven Joffe – Dana-Farber Cancer Institute, Boston - Ethics of early-phase clinical trials on ecancer tv. Cancer journal: online cancer news, clinical oncology research, cancer information and latest cancer studies - open access cancer journal: ecancermedicalscience

›
Ethics of early-phase clinical trials Dr Joffe talks to ecancer tv at ASCO 2011 about the arguments around patient recruitment and expe...
1 comment: